共 107 条
[1]
Jones GL(2015)British Committee for Standards in Haematology. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology Br J Haematol 169 661-671
[2]
Will A(2004)Tumour lysis syndrome: new therapeutic strategies and classification Br J Haematol 127 3-11
[3]
Jackson GH(2010)TLS expert panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus Br J Haematol 149 578-586
[4]
Webb NJ(2012)Onco-nephrology: tumor lysis syndrome Clin J Am Soc Nephrol 7 1730-1739
[5]
Rule S(2008)Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review J Clin Oncol 26 2767-2778
[6]
Cairo MS(2019)Tumor lysis syndrome Arch Pathol Lab Med 143 386-393
[7]
Bishop M(2011)The tumor Lysis syndrome N Engl J Med 364 1844-1854
[8]
Cairo MS(2016)Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol Int J Clin Oncol 21 996-1003
[9]
Coiffier B(2010)Control of plasma uric acid in adults at risk for tumor lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study J Clin Oncol 28 4207-4213
[10]
Reiter A(2015)Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma Blood Cancer J 5 e349-917